Cencora 

$219.94
241
-$1.02-0.46% Friday 20:00

統計

當日最高
221.15
當日最低
219.35
52週最高
247.66
52週最低
182.62
成交量
1,581,839
平均成交量
1,435,339
市值
46.96B
市盈率
25.98
股息收益率
0.93%
股息
2.04

即將到來

股息

0.93%股息收益率
10年增長
7.44%
5年增長率
4.98%
3年增長率
4.65%
1年增長率
3.82%

收益

6Nov預期
Q2 2022
Q3 2022
Q3 2023
Q4 2023
Q1 2024
Q2 2024
下一個
2.57
2.98
3.39
3.8
預期每股收益
3.2
實際每股收益
N/A

人們還關注

此列表基於在 Stock Events 上關注 COR 的人的關注列表。這不是投資建議。

競爭者

這個列表是基於最近市場事件的分析。這不是投資建議。

分析師評級

269.83$平均價格目標
最高估價為 $287。
來自過去 6 個月內的 6 個評級。這不是投資建議。
買入
67%
持有
33%
賣出
0%

關於

Finance
Real Estate Investment Trusts
Finance and Insurance
Other Financial Vehicles
Cencora, Inc. sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The company also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; and pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. The company's International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; and distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers and hospitals primarily in Europe. This segment also provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.
Show more...
首席執行官
Steven Collis
員工
46000
國家
US
ISIN
US03073E1055

上市公司